Mark F. Bear
11Patents
5h-index
13Co-inventors
59Inventor score
Filing activity: Apr 2, 2002 → Nov 30, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8143311B2 | Methods of treating fragile X syndrome and autism | Human Necessities | 19 | Active |
| US8273715B2 | Methods of treating fragile X syndrome | Human Necessities | 17 | Active |
| US8278276B2 | Methods of treating autism | Human Necessities | 17 | Active |
| US6890931B2 | Methods of treating disorders with group I mGluR antagonists | Human Necessities | 8 | Expired |
| US6916821B2 | Methods of treating disorders with Group I mGluR antagonists | Human Necessities | 7 | Expired |
| US7648993B2 | Methods of treating disorders with Group I mGluR antagonists | Human Necessities | 3 | Active |
| US9834819B2 | Methods for diagnosing autism spectrum disorders | Chemistry; Metallurgy | 2 | Active |
| US10682397B2 | Methods of treating fragile X syndrome and related disorders | Chemistry; Metallurgy | 0 | Active |
| US10596176B2 | Methods to treat visual impairment | Human Necessities | 0 | Active |
| US10655178B2 | Methods for diagnosing autism spectrum disorders | Chemistry; Metallurgy | 0 | Active |
| US9044443B2 | Methods of treating autism | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.